Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | ESR2 | Q92731 | 11/20 | 0.56 |
| ▸ | ESR1 | P03372 | 10/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.52 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.52 |
| ▸ | BCR | P11274 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.50 |
| ▸ | F12 | P00748 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23371164 | 0.89 | CYP1A2 (0.56) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL29973107 | 0.88 | CYP1A2 (0.68) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL755928 | 0.88 | CYP1A2 (0.68) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL29405718 | 0.88 | CYP1A2 (0.68) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL392290 | 0.88 | CYP1A2 (0.68) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL3451975 | 0.88 | CYP1A2 (0.78) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL69484 | 0.87 | CYP1A2 (0.77) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL627219 | 0.87 | CYP1A2 (0.77) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL29364786 | 0.87 | CYP1A2 (0.77) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL20169579 | 0.86 | CYP1A2 (0.48) | CYP1A2ESR2ESR1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260133485-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND UNDERLAYER FILM-FORMING COMPOSITION | JSR CORPORATION (JP) | 2026-05-14 | — | — | US | disclosed |
| US-20260093180-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND COMPOSITION FOR FILM FORMATION | JSR CORPORATION (JP) | 2026-04-02 | — | — | US | disclosed |
| EP-4606882-A1 | CLEANING SOLUTION, METHOD FOR CLEANING SUBSTRATE, AND METHOD FOR FORMING METAL-CONTAINING FILM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-20250263639-A1 | Cleaning Solution, Method For Cleaning Substrate, And Method For Forming Metal Containing Film | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-08-21 | — | — | US | disclosed |
| EP-4600734-A1 | PATTERN FORMING METHOD AND LAMINATE | Shin-Etsu Chemical Co., Ltd. (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-20250246429-A1 | Pattern Forming Method And Laminate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-07-31 | — | — | US | disclosed |
| WO-2025079496-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE | JSR株式会社 | 2025-04-17 | — | — | WO | disclosed |
| WO-2025041533-A1 | SEMICONDUCTOR SUBSTRATE PRODUCTION METHOD AND FILM-FORMING COMPOSITION | JSR株式会社 | 2025-02-27 | — | — | WO | disclosed |
| WO-2025013817-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE, AND UNDERLAYER FILM-FORMING COMPOSITION FOR FIRST METAL-CONTAINING RESIST | JSR株式会社 | 2025-01-16 | — | — | WO | disclosed |
| US-20240369931-A1 | METHOD OF MANUFACTURING SEMICONDUCTOR SUBSTRATE, METHOD FOR FORMING RESIST UNDERLAYER FILM, AND CLEANING LIQUID | JSR CORPORATION (JP) | 2024-11-07 | — | — | US | disclosed |
| US-20060014696-A1 | Modulators of beta-amyloid peptide aggregation comprising D-amino acids | PRAECIS PHARMACEUTICALS, INC. (US) | 2006-01-19 | — | — | US | disclosed |
| EP-1586584-A1 | Modulators of beta-amyloid peptide aggregation comprising D-amino acids | Praecis Pharmaceuticals Incorporated (US) | 2005-10-19 | — | — | EP | disclosed |
| EP-0929574-B1 | MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | PRAECIS PHARM INC (US) | 2005-06-29 | — | — | EP | disclosed |
| US-20050084464-A1 | Method for reducing odor using metal-modified particles | KIMBERLY-CLARK WORLDWIDE, INC. | 2005-04-21 | — | — | US | disclosed |
| US-6689752-B2 | AMINO-TERMINAL MODIFYING GROUPS INCLUDE CYCLIC, HETEROCYCLIC, POLYCYCLIC AND BRANCHED ALKYLS, AND CARBOXY-TERMINAL MODIFYING GROUPS INCLUDE AN AMIDE, AN ALKYL AMIDE, AN ARYL AMIDE OR A HYDROXY; TREATING ALZHEIMER'S DISEASE | PRAECIS PHARMACEUTICALS, INCORPORATED | 2004-02-10 | — | — | US | disclosed |
| EP-0810249-B1 | Thermosetting resin composition, electrically insulated coil, electric rotating machine and method for producing same | HITACHI LTD (JP) | 2001-11-07 | — | — | EP | disclosed |
| US-5982056-A | STATOR OF ROTATING MACHINE | HITACHI, LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0810249-A2 | Thermosetting resin composition, electrically insulated coil, electric rotating machine and method for producing same | HITACHI, LTD. (JP) | 1997-12-03 | — | — | EP | disclosed |
| US-5208390-A | Organic sulfonation catalysts for alkylation of aromatic polyols | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1993-05-04 | — | — | US | disclosed |
| US-4350534-A | Fluid, stable formulations of copper phthalocyanine or indanthrone | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260093180-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND COMPOSITION FOR FILM FORMATION | SMC4, TYR, SMC2 | CYP1A2 297/4885ESR2 2855/4885ESR1 3058/4885 |
| US-20050084464-A1 | Method for reducing odor using metal-modified particles | OR10J3, OR51E2, ORAI2 | CYP1A2 4711/4885ESR2 2943/4885ESR1 3009/4885 |
| US-20060014696-A1 | Modulators of beta-amyloid peptide aggregation comprising D-amino acids | APP, IAPP, BACE1 | CYP1A2 4155/4885ESR2 1939/4885ESR1 3309/4885 |
| US-20260133485-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND UNDERLAYER FILM-FORMING COMPOSITION | TWF2, TERF2, TPR | CYP1A2 2496/4885ESR2 3352/4885ESR1 2434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.